The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering
Open accessAbstract
Mice carrying mutations in multiple genes are traditionally generated by sequential recombination in embryonic stem cells and/or time-consuming intercrossing of mice with a single mutation. The CRISPR/Cas system has been adapted as an efficient gene-targeting technology with the potential for multiplexed genome editing. We demonstrate that CRISPR/Cas-mediated gene editing allows the simultaneous disruption of five genes (Tet1, 2, 3, Sry, Uty--8 alleles) in mouse embryonic stem (ES) cells with high efficiency. Coinjection of Cas9 mRNA and single-guide RNAs (sgRNAs) targeting Tet1 and Tet2 into zygotes generated mice with biallelic mutations in both genes with an efficiency of 80%. Finally, we show that coinjection of Cas9 mRNA/sgRNAs with mutant oligos generated precise point mutations simultaneously in two target genes. Thus, the CRISPR/Cas system allows the one-step generation of animals carrying mutations in multiple genes, an approach that will greatly accelerate the in vivo study of functionally redundant genes and of epistatic gene interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Soon, all sorts of cells and some multicellular organisms would be the object of CRISPR-mediated manipulation, such as human cell cultures, mice, plants, yeasts, and the list goes on [62,63,64,65].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“The need for specific proteins tailored for each gene also makes multiplex gene editing a strenuous task for ZFNs and TALENs, while with Cas9 systems multiple genes can be targeted simply by delivering multiple gRNAs to the cells [63,98].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“focused on the issue of human germline engineering, as the methods have already been demonstrated in mice (6) and monkeys (7).”
From A prudent path forward for genomic engineering and germline gene modification (2015) · cites this paper as [6]
In the citing paper
“However, the desired recombination efficacy often occurs infrequently, which presents enormous challenges for robust applications [61, 82–84].”
From Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities (2018) · cites this paper as [61]
In the citing paper
“Recently, the CRISPR/Cas system has been successfully applied to human cells19,20,21,22 and several model organisms for genome editing.23,24,25,26”
From The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo (2014) · cites this paper as [26]
In the citing paper
“DNA sequence recognition requires only a single 20-nt guide RNA and a protospacer adjacent motif, which enables one to rapidly engineer and test a large number of DNA cleavage sites (17)(18)(19)(20).”
From RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection (2014) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Gasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,471
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Self-citationGenome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,005
Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ
Aida, T., Nakade, S., Sakuma, T., Izu, Y., Oishi, A., Mochida, K., Ishikubo, H., Usami, T., Aizawa, H., Yamamoto, T., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-3331-9 · Cited by 74
Engineering Xenopus embryos for phenotypic drug discovery screening
Schmitt, S. M., Gull, M., & Brändli, A. W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.02.004 · Cited by 74
May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
Brookhouser, N., Raman, S., Potts, C., & Brafman, D. A. (2017) · Cells · doi:10.3390/cells6010005 · Cited by 75
Genome engineering: a new approach to gene therapy for neuromuscular disorders
Nelson, C. E., Robinson-Hamm, J. N., & Gersbach, C. A. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.126 · Cited by 73
Zuo, W., Chen, G., Gao, Z., Li, S., Chen, Y., Huang, C., Chen, J., Chen, Z., Lei, M., & Bian, Q. (2021) · Nature Communications · doi:10.1038/s41467-021-26033-0 · Cited by 63
Evolution of Gene Regulation in Humans
Reilly, S. K., & Noonan, J. P. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090314-045935 · Cited by 66
CRISPR/Cas9-Based Genome Editing in Mice by Single Plasmid Injection
Fujihara, Y., & Ikawa, M. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00015-5 · Cited by 70
mRNA-based therapeutics–Advances and perspectives
Sergeeva, O. V., Koteliansky, V., & Zatsepin, T. S. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916070075 · Cited by 74
Efficient Screening of CRISPR/Cas9-Induced Events in Drosophila Using a Co-CRISPR Strategy
Kane, N. S., Vora, M., Varre, K. J., & Padgett, R. W. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.116.036723 · Cited by 71
Tang, N., Zhang, Y., Pedrera, M., Chang, P., Baigent, S. J., Moffat, K., Shen, Z., Nair, V., & Yao, Y. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.12.025 · Cited by 71
Tu, C., Nie, H., Meng, L., Wang, W., Li, H., Yuan, S., Cheng, D., He, W., Liu, G., Du, J., et al. (2020) · Human Genetics · doi:10.1007/s00439-020-02110-0 · Cited by 72
New prospects on the horizon: Genome editing to engineer plants for desirable traits
Iqbal, Z., Iqbal, M. S., Ahmad, A., Memon, A. G., & Ansari, M. I. (2020) · Current Plant Biology · doi:10.1016/j.cpb.2020.100171 · Cited by 70
Cyclin D3 drives inertial cell cycling in dark zone germinal center B cells
Pae, J., Ersching, J., Castro, T. B. R., Schips, M., Mesin, L., Allon, S. J., Ordovás-Montañés, J., Mlynarczyk, C., Melnick, A. M., Efeyan, A., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201699 · Cited by 71
Strategies for genetic manipulation of adult stem cell-derived organoids
Menche, C., & Farin, H. F. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00609-8 · Cited by 72
Dougnon, G., & Matsui, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147550 · Cited by 76
Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing
Farsani, A. M., Mokhtari, N., Nooraei, S., Bahrulolum, H., Akbari, A., Farsani, Z. M., Khatami, S., Ebadi, M. S., & Ahmadian, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24606 · Cited by 82
Functional interpretation of non‐coding sequence variation: Concepts and challenges
Paul, D. S., Soranzo, N., & Beck, S. (2013) · BioEssays · doi:10.1002/bies.201300126 · Cited by 70
Cas9-Based Tools for Targeted Genome Editing and Transcriptional Control
Xu, T., Li, Y., Nostrand, J. D. V., He, Z., & Zhou, J. Z. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03786-13 · Cited by 71
Hyakusoku, H., Sano, D., Takahashi, H., Hatano, T., Isono, Y., Shimada, S., Ito, Y., Myers, J. N., & Oridate, N. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0284-4 · Cited by 70
Otterloo, E. V., Williams, T., & Artinger, K. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.01.017 · Cited by 67
Li, Z., Peng, Y., Hufnagel, R. B., Hu, Y., Zhao, C., Queme, L. F., Khuchua, Z. A., Driver, A. M., Dong, F., Lu, Q. R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx262 · Cited by 70
Distilling Pathophysiology from Complex Disease Genetics
Chakravarti, A., Clark, A. G., & Mootha, V. K. (2013) · Cell · doi:10.1016/j.cell.2013.09.001 · Cited by 70
CRISPR-Mediated VHL Knockout Generates an Improved Model for Metastatic Renal Cell Carcinoma
Schokrpur, S., Hu, J., Moughon, D. L., Liu, P., Lin, L. C., Hermann, K. J., Mangul, S., Guan, W., Pellegrini, M. A., Xu, H., et al. (2016) · Scientific Reports · doi:10.1038/srep29032 · Cited by 70
CRISPR/Cas9 gene-editing strategies in cardiovascular cells
Vermersch, E., Jouve, C., & Hulot, J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz250 · Cited by 74
LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages
Wei, Z., Oh, J., Flavell, R. A., & Crawford, J. M. (2022) · Nature · doi:10.1038/s41586-022-05111-3 · Cited by 69
Ionizable Lipid Nanoparticles for mRNA Delivery
Tang, X., Zhang, Y., & Han, X. (2023) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300006 · Cited by 76
CRISPR–Cas system: a powerful tool for genome engineering
Liu, L., & Fan, X.-D. (2014) · Plant Molecular Biology · doi:10.1007/s11103-014-0188-7 · Cited by 73
RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
Gasiūnas, G., & Šikšnys, V. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.09.001 · Cited by 70
Genetic and Genomic Tools for the Marine AnnelidPlatynereis dumerilii
Zantke, J., Bannister, S. C., Rajan, V. B. V., Raible, F., & Tessmar‐Raible, K. (2014) · Genetics · doi:10.1534/genetics.112.148254 · Cited by 72
Liang, X., Sun, L., Teng, Y., Pan, Y., Wang, D., Hu, X., Fu, Z., He, Q., & Cao, G. (2016) · Scientific Reports · doi:10.1038/srep19176 · Cited by 69
In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
Schuh, R. S., Poletto, É., Pasqualim, G., Tavares, Â. M. V., Meyer, F. S., Gonzalez, E. A., Giugliani, R., Matte, Ú. D. S., Teixeira, H. F., & Baldo, G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.031 · Cited by 70
Schwartz, D. M., Farley, T. K., Richoz, N., Yao, C., Shih, H., Petermann, F., Zhang, Y., Sun, H., Hayes, E. T., Mikami, Y., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.014 · Cited by 69
Nanoparticles-mediated CRISPR/Cas9 delivery: Recent advances in cancer treatment
Aghamiri, S., Talaei, S., Ghavidel, A. A., Zandsalimi, F., Masoumi, S., Hafshejani, N. H., & Jajarmi, V. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101533 · Cited by 70
FTD and ALS—translating mouse studies into clinical trials
Ittner, L. M., Halliday, G. M., Kril, J. J., Götz, J., Hodges, J. R., & Kiernan, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.65 · Cited by 70
Guo, Y., Redmond, C. J., Leacock, K. A., Brovkina, M. V., Ji, S., Jaskula-Ranga, V., & Coulombe, P. A. (2020) · eLife · doi:10.7554/elife.53165 · Cited by 69
Kim, E. S., Yoon, B. H., Lee, S. M., CHOI, M. H., Kim, E. H., Lee, B.-W., Kim, S., Pack, C., Sung, Y. H., Baek, I., et al. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00728-w · Cited by 67
Gene editing and its applications in biomedicine
Li, G., Li, X., Zhuang, S., Wang, L., Zhu, Y., Chen, Y., Sun, W. C., Wu, Z., Zhou, Z. L., Chen, J., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2057-0 · Cited by 66
Self-citationHighly efficient generation of isogenic pluripotent stem cell models using prime editing
Li, H., Busquets, O., Verma, Y., Syed, K. M., Kutnowski, N., Pangilinan, G. R., Gilbert, L. A., Bateup, H. S., Rio, D. C., Hockemeyer, D. F., et al. (2022) · eLife · doi:10.7554/elife.79208 · Cited by 69
Faresse, N. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.015 · Cited by 68
Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice
Ishizu, N., Yui, D., Hebisawa, A., Aizawa, H., Cui, W., Fujita, Y., Hashimoto, K., Ajioka, I., Mizusawa, H., Yokota, T., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw279 · Cited by 71
Emerging Sponge Models of Animal-Microbe Symbioses
Pita, L., Fraune, S., & Hentschel, U. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02102 · Cited by 70
Honda, A., Hirose, M., Sankai, T., Yasmin, L., Yuzawa, K., Honsho, K., Izu, H., Iguchi, A., Ikawa, M., & Ogura, A. (2014) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.14-0034 · Cited by 67
Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies
McTague, A., Rossignoli, G., Ferrini, A., Barral, S., & Kurian, M. A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.630600 · Cited by 67
CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Bloomer, H., Khirallah, J., Li, Y., & Xu, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114087 · Cited by 75
CRISPR/Cas9-mediated GJA8 knockout in rabbits recapitulates human congenital cataracts
Yuan, L., Sui, T., Chen, M., Deng, J., Huang, Y., Zeng, J., Lv, Q., Song, Y., Li, Z., & Lai, L. (2016) · Scientific Reports · doi:10.1038/srep22024 · Cited by 67
Abe, H., Alavattam, K. G., Hu, Y., Pang, Q., Andreassen, P. R., Hegde, R. S., & Namekawa, S. H. (2020) · Current Biology · doi:10.1016/j.cub.2019.11.064 · Cited by 58
CRISPR Gene Editing in the Kidney
Cruz, N. M., & Freedman, B. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.02.347 · Cited by 69
Genome Editing in Mice Using CRISPR/Cas9 Technology
Hall, B., Cho, A., Limaye, A., Cho, K., Khillan, J. S., & Kulkarni, A. B. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.57 · Cited by 72
TEX15 is an essential executor of MIWI2-directed transposon DNA methylation and silencing
Schöpp, T., Zoch, A., Berrens, R. V., Auchynnikava, T., Kabayama, Y., Vasiliauskaitė, L., Rappsilber, J., Allshire, R. C., & O’Carroll, D. (2020) · Nature Communications · doi:10.1038/s41467-020-17372-5 · Cited by 68
Evolving AAV-delivered therapeutics towards ultimate cures
He, X., Urip, B. A., Zhang, Z., Ngan, C. C., & Feng, B. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-020-02034-2 · Cited by 70
Efficient generation of genome-modified mice via offset-nicking by CRISPR/Cas system
Fujii, W., Onuma, A., Sugiura, K., & Naito, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.141 · Cited by 66
Digital PCR to assess gene-editing frequencies (GEF-dPCR) mediated by designer nucleases
Mock, U., Hauber, I., & Fehse, B. (2016) · Nature Protocols · doi:10.1038/nprot.2016.027 · Cited by 70
Rizzo, S. J. S., & Crawley, J. N. (2017) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022516-022754 · Cited by 67
Cooper, C. A., Challagulla, A., Jenkins, K. A., Wise, T. G., O’Neil, T. E., Morris, K. R., Tizard, M. L., & Doran, T. J. (2016) · Transgenic Research · doi:10.1007/s11248-016-0003-0 · Cited by 68
A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies
McHugh, D. R., Steele, M., Valerio, D. M., Miron, A., Mann, R. J., LePage, D. F., Conlon, R. A., Cotton, C. U., Drumm, M. L., & Hodges, C. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199573 · Cited by 69
Self-Replicating RNA Viruses for RNA Therapeutics
Lundstrom, K. H. (2018) · Molecules · doi:10.3390/molecules23123310 · Cited by 66
Viral Resistance and IFN Signaling in STAT2 Knockout Fish Cells
Dehler, C. E., Lester, K., Pelle, G. D., Jouneau, L., Houël, A., Collins, C., Dovgan, T., Machát, R., Zou, J., Boudinot, P., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801376 · Cited by 68
Removal of alleles by genome editing (RAGE) against deleterious load
Johnsson, M., Gaynor, R. C., Jenko, J., Gorjanc, G., de Koning, D., & Hickey, J. M. (2019) · Genetics Selection Evolution · doi:10.1186/s12711-019-0456-8 · Cited by 68
Galupa, R., Nora, E. P., Worsley-Hunt, R., Picard, C., Gard, C., van Bemmel, J. G., Servant, N., Zhan, Y., Marjou, F. E., Johanneau, C., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.10.030 · Cited by 71
Optimizing mouse models for precision cancer prevention
Magnen, C. L., Dutta, A., & Abate-Shen, C. T. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.1 · Cited by 65
Genome editing in cardiovascular diseases
Mani, I. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.021 · Cited by 66
Sox2 Controls Neural Stem Cell Self-Renewal Through a Fos -Centered Gene Regulatory Network
Pagin, M., Pernebrink, M., Giubbolini, S., Barone, C., Sambruni, G., Zhu, Y., Chiara, M., Ottolenghi, S., Pavesi, G., Wei, C., et al. (2021) · Stem Cells · doi:10.1002/stem.3373 · Cited by 61
Control of mouse limb initiation and antero-posterior patterning by Meis transcription factors
Delgado, I., Giovinazzo, G., Temiño, S., Gauthier, Y., Balsalobre, A., Drouin, J., & Torres, M. (2021) · Nature Communications · doi:10.1038/s41467-021-23373-9 · Cited by 66
Chrysanthou, S., Tang, Q., Lee, J., Taylor, S. J., Zhao, Y., Steidl, U. G., Zheng, D., & Dawlaty, M. M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac089 · Cited by 64
Self-citationAntibody validation for Western blot: By the user, for the user
Pillai‐Kastoori, L., Heaton, S., Shiflett, S. D., Roberts, A. C., Solache, A., & Schutz-Geschwender, A. R. (2020) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)49905-4 · Cited by 69
Shaping faces: genetic and epigenetic control of craniofacial morphogenesis
Selleri, L., & Rijli, F. M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00594-w · Cited by 70
The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
Zhu, Z., González, F., & Huangfu, D. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801185-0.00011-8 · Cited by 66
Strategies for precision modulation of gene expression by epigenome editing: an overview
Laufer, B. I., & Singh, S. M. (2015) · Epigenetics & Chromatin · doi:10.1186/s13072-015-0023-7 · Cited by 70
Nuclease‐mediated genome editing: At the front‐line of functional genomics technology
Sakuma, T., & Woltjen, K. (2014) · Development Growth & Differentiation · doi:10.1111/dgd.12111 · Cited by 70
de Solis, C. A., Ho, A., Holehonnur, R., & Ploski, J. E. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00070 · Cited by 65
Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review
Dangi, A. K., Sinha, R., Dwivedi, S., Gupta, S. K., & Shukla, P. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00630 · Cited by 66
Creating cell and animal models of human disease by genome editing using CRISPR/Cas9
Zarei, A., Razban, V., Hosseini, S. E., & Tabei, K. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3082 · Cited by 68
CRISPR-Cas9 system: A genome-editing tool with endless possibilities
Tyagi, S., Kumar, R., Das, A., Won, S. Y., & Shukla, P. (2020) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2020.05.008 · Cited by 71
miR-26 suppresses adipocyte progenitor differentiation and fat production by targeting Fbxl19Preprint
Acharya, A., Berry, D. C., Zhang, H., Jiang, Y., Jones, B. T., Hammer, R. E., Graff, J. M., & Mendell, J. T. (2019) · Genes & Development · doi:10.1101/gad.328955.119 · Cited by 69
Generation of targeted mouse mutants by embryo microinjection of TALEN mRNA
Wefers, B., Panda, S. K., Ortiz, O., Brandl, C., Hensler, S., Hansen, J., Wurst, W., & Kühn, R. (2013) · Nature Protocols · doi:10.1038/nprot.2013.142 · Cited by 58
Applying CRISPR–Cas9 tools to identify and characterize transcriptional enhancers
Lopes, R., Korkmaz, G., & Agami, R. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.79 · Cited by 65
Zhao, K.-R., Wang, L., Liu, P., Hang, X.-M., Wang, H., Ye, S.-Y., Liu, Z., & Liang, G. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130485 · Cited by 64
Self-citationCRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 65
Application of CRISPR/Cas9 genome editing to the study and treatment of disease
Pellagatti, A., Dolatshad, H., Valletta, S., & Boultwood, J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1504-y · Cited by 65
Karigo, T., & Oka, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00177 · Cited by 65
Designed nucleases for targeted genome editing
Lee, J., Chung, J., Kim, H. M., Kim, S., & Kim, S. (2015) · Plant Biotechnology Journal · doi:10.1111/pbi.12465 · Cited by 70
Somatic cell nuclear transfer: origins, the present position and future opportunities
Wilmut, I., Bai, Y., & Taylor, J. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0366 · Cited by 64
Uemura, T., Mori, T., Kurihara, T., Kawase, S., Koike, R., Satoga, M., Cao, X., Li, X., Yanagawa, T., Sakurai, T., et al. (2016) · Scientific Reports · doi:10.1038/srep35861 · Cited by 65
Ye, Z., Liu, X.-L., Han, Q., Liao, H., Dong, X., Zhu, G., & Dong, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08769-2 · Cited by 64
Use of gene-editing technology to introduce targeted modifications in pigs
Ryu, J., Prather, R. S., & Lee, K. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0228-7 · Cited by 65
From engineering to editing the rat genome
Meek, S., Mashimo, T., & Burdon, T. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9705-8 · Cited by 63
A practical guide to induced pluripotent stem cell research using patient samples
Santostefano, K. E., Hamazaki, T., Biel, N. M., Jin, S., Umezawa, A., & Terada, N. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.104 · Cited by 62
Precision genetic modifications: a new era in molecular biology and crop improvement
Fichtner, F., Urrea-Castellanos, R., & Ülker, B. (2014) · Planta · doi:10.1007/s00425-014-2029-y · Cited by 67
Kanda, M., Shimizu, D., Sawaki, K., Nakamura, S., Umeda, S., Miwa, T., Tanaka, H., Tanaka, C., Hayashi, M., Iguchi, Y., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01251-0 · Cited by 67
Oliver, D., Yuan, S., McSwiggin, H., & Yan, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129457 · Cited by 60
CRISPR–Cas9-mediated genome editing and guide RNA design
Wiles, M. V., Qin, W., Cheng, A. W., & Wang, H. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9565-z · Cited by 67
Self-citationEfficient bi-allelic gene knockout and site-specific knock-in mediated by TALENs in pigs
Yao, J. T., Huang, J., Hai, T., Wang, X., Qin, G., Zhang, H., Wu, R., Cao, C., Xi, J., Yuan, Z., et al. (2014) · Scientific Reports · doi:10.1038/srep06926 · Cited by 63
Mashimo, T. (2013) · Development Growth & Differentiation · doi:10.1111/dgd.12110 · Cited by 70
Update of neurotrophic factors in neurobiology of addiction and future directions
Koskela, M., Bäck, S., Võikar, V., Richie, C. T., Domanskyi, A., Harvey, B. K., & Airavaara, M. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.010 · Cited by 72
Rastogi, A., Murik, O., Bowler, C., & Tirichine, L. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1143-1 · Cited by 63
Idoko-Akoh, A., Taylor, L., Sang, H., & McGrew, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-33244-x · Cited by 62
Meiosis I progression in spermatogenesis requires a type of testis-specific 20S core proteasome
Zhang, Q., Ji, S., Busayavalasa, K., Shao, J., & Yu, C. Y. (2019) · Nature Communications · doi:10.1038/s41467-019-11346-y · Cited by 63
Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons
Ivics, Z., Mátés, L., Yau, T. Y., Landa, V., Zı́dek, V., Bashir, S., Hoffmann, O. I., Hiripi, L., Garrels, W., Kues, W. A., et al. (2014) · Nature Protocols · doi:10.1038/nprot.2014.008 · Cited by 63
Spielmann, M., Kakar, N., Tayebi, N., Leettola, C. N., Nürnberg, G., Sowada, N., Lupiáñez, D. G., Harabula, I., Flöttmann, R., Horn, D., et al. (2016) · Genome Research · doi:10.1101/gr.199430.115 · Cited by 62
Sperm Postacrosomal WW Domain-Binding Protein Is Not Required for Mouse Egg Activation1
Satouh, Y., Nozawa, K., & Ikawa, M. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.131441 · Cited by 65
Metadata
- Authors
- Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Broad Institute (US)
- Corresponding author
- Jaenisch, Rudolf
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 153
- Issue
- 4
- Pages
- 910-918
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC3969854
- OpenAlex
- W2170039745
- Cited by
- 3,495
- References
- 35
- Citations by year
- 2026: 63 · 2025: 94 · 2024: 166 · 2023: 203 · 2022: 210 · 2021: 239 · 2020: 286 · 2019: 299 · 2018: 332 · 2017: 352 · 2016: 392 · 2015: 362 · 2014: 359 · 2013: 134
- FWCI
- 186.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- PMC
- Funders
- Damon Runyon Cancer Research Foundation
- National Institutes of Health (2r01ca084198-10)
- National Institute of Mental Health (DP1MH100706)
- National Cancer Institute (R01-CA084198)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R37HD045022)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas genome editing, multiplexed genome editing, mouse mutagenesis, TET1, TET2, TET3, SRY, UTY, biallelic variants, single guide RNA, zygote injection, mouse embryonic stem cells
- MeSH terms
- Animals, Base Sequence, Female, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Molecular Sequence Data, Gene Targeting, Mice, Embryonic Stem Cells, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
